OTLK logo

Outlook Therapeutics (OTLK) Return On Assets

Annual ROA

-261.48%
-78.87%-43.19%

September 30, 2024


Summary


Performance

OTLK ROA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherOTLKprofitabilitymetrics:

Quarterly ROA

-192.47%
+42.50%+18.09%

September 1, 2024


Summary


Performance

OTLK Quarterly ROA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherOTLKprofitabilitymetrics:

ROA Formula

ROA =  Net Income
Total Assets
✕ 100%

OTLK ROA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-43.2%-42.4%
3 y3 years-12.2%-2.6%
5 y5 years-49.3%+3.4%

OTLK ROA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-43.2%at low-62.7%+52.4%
5 y5-year-49.3%at low-62.7%+52.4%
alltimeall time-566.5%at low-109.8%+52.4%

Outlook Therapeutics ROA History

DateAnnualQuarterly
Sep 2024
-261.48%(+43.2%)
-
Sep 2024
-
-192.47%(-18.1%)
Jun 2024
-
-234.97%(-41.9%)
Mar 2024
-
-404.25%(+199.2%)
Dec 2023
-
-135.12%(+10.8%)
Sep 2023
-182.61%(-21.1%)
-121.95%(-4.1%)
Jun 2023
-
-127.23%(+2.2%)
Mar 2023
-
-124.47%(-12.5%)
Dec 2022
-
-142.29%(+15.0%)
Sep 2022
-231.54%(-0.6%)
-123.76%(-1.3%)
Jun 2022
-
-125.36%(+5.9%)
Mar 2022
-
-118.32%(-0.2%)
Dec 2021
-
-118.50%(-36.9%)
Sep 2021
-233.05%(+30.5%)
-187.65%(+4.1%)
Jun 2021
-
-180.26%(+19.7%)
Mar 2021
-
-150.55%(-13.9%)
Dec 2020
-
-174.95%(-8.7%)
Sep 2020
-178.59%
-191.60%(-4.0%)
Jun 2020
-
-199.60%(+0.2%)
DateAnnualQuarterly
Mar 2020
-
-199.29%(-6.2%)
Dec 2019
-
-212.38%(+33.5%)
Sep 2019
-175.17%(+25.2%)
-159.07%(+9.0%)
Jun 2019
-
-145.97%(-13.7%)
Mar 2019
-
-169.19%(+20.6%)
Dec 2018
-
-140.27%(+27.9%)
Sep 2018
-139.91%(-16.9%)
-109.69%(+19.3%)
Jun 2018
-
-91.91%(+0.2%)
Mar 2018
-
-91.72%(-8.5%)
Dec 2017
-
-100.29%(-47.8%)
Sep 2017
-168.40%(-4.6%)
-191.99%(+1.2%)
Jun 2017
-
-189.73%(-23.4%)
Mar 2017
-
-247.82%(+22.7%)
Dec 2016
-
-201.99%(+15.2%)
Sep 2016
-176.45%(+30.3%)
-175.29%(-7.4%)
Jun 2016
-
-189.21%(+20.7%)
Mar 2016
-
-156.70%(-9.2%)
Dec 2015
-
-172.51%(+27.4%)
Sep 2015
-135.38%(+245.1%)
-135.38%
Sep 2014
-39.23%
-

FAQ

  • What is Outlook Therapeutics annual return on assets?
  • What is the all time high annual ROA for Outlook Therapeutics?
  • What is Outlook Therapeutics annual ROA year-on-year change?
  • What is Outlook Therapeutics quarterly return on assets?
  • What is the all time high quarterly ROA for Outlook Therapeutics?
  • What is Outlook Therapeutics quarterly ROA year-on-year change?

What is Outlook Therapeutics annual return on assets?

The current annual ROA of OTLK is -261.48%

What is the all time high annual ROA for Outlook Therapeutics?

Outlook Therapeutics all-time high annual return on assets is -39.23%

What is Outlook Therapeutics annual ROA year-on-year change?

Over the past year, OTLK annual return on assets has changed by -78.87% (-43.19%)

What is Outlook Therapeutics quarterly return on assets?

The current quarterly ROA of OTLK is -192.47%

What is the all time high quarterly ROA for Outlook Therapeutics?

Outlook Therapeutics all-time high quarterly return on assets is -91.72%

What is Outlook Therapeutics quarterly ROA year-on-year change?

Over the past year, OTLK quarterly return on assets has changed by -57.35% (-42.44%)